- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Breast Cancer
Total 57483 results
-
CelltrionUnknownMetastatic Breast CancerRomania
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticFrance, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
-
Tokyo Medical UniversityTokyo University; Saint Luca International HospitalCompleted
-
Accelerated Community Oncology Research NetworkBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States
-
Claudia Lorenz-SchlüterTerminatedMetastatic Breast CancerGermany
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Breakthrough Breast CancerUnknown
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
Genentech, Inc.Completed
-
M.D. Anderson Cancer CenterCTI BioPharmaCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterAventis Pharmaceuticals; Rhone-Poulenc RorerCompletedMetastatic Breast CancerUnited States
-
Centre Georges Francois LeclercSanofi; GlaxoSmithKlineCompletedMetastatic Breast CancerFrance
-
Adherex Technologies, Inc.UnknownMetastatic Breast CancerUnited States, Russian Federation
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany
-
Novartis PharmaceuticalsTerminated
-
AgennixCompleted
-
Cancer Research NetworkHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.CompletedMetastatic Breast CancerChina
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
National Cancer Center, KoreaCompletedGoserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCMetastatic Breast CancerKorea, Republic of
-
Taiwan THL Co.LTd.National Taiwan University HospitalCompletedMetastatic Breast CancerTaiwan
-
Hoosier Cancer Research NetworkSanofi; Hoffmann-La Roche; Walther Cancer InstituteTerminatedMetastatic Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Beijing Shenogen Biomedical Co., LtdUnknownMetastatic Breast CancerChina
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast CancerKorea, Republic of
-
Genentech, Inc.Terminated
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
McGill UniversityUnknownMetastatic Breast CancerCanada
-
University of Michigan Rogel Cancer CenterTerminated
-
Herlev HospitalTerminated
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Forward Pharmaceuticals Co., Ltd.RecruitingMetastatic Breast Cancer | Breast Cancer Stage I | Locally Advanced Breast Cancer | ER+ Breast CancerChina
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Leptomeningeal Metastases | Recurrent Breast Cancer | Central Nervous System Metastases | Tumors Metastatic to BrainUnited States
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
SCRI Development Innovations, LLCDaiichi Sankyo, Inc.RecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
Consorzio OncotechRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerItaly
-
Rhizen Pharmaceuticals SACompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGeorgia
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
Heidelberg UniversityDafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger...CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGermany
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden